These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10048009)

  • 1. [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
    Lachmann C; Jörg KM; Trinkmann R
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):326-30. PubMed ID: 10048009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group.
    Hartenbaum D; Wilson H; Maloney S; Vacarelli L; Orillac R; Sharpe E
    J Glaucoma; 1999 Aug; 8(4):273-5. PubMed ID: 10464738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma].
    Sesar A; Petric I; Sesar I; Lacmnovic-Loncar V; Jurisić D; Tomić Z; Mandić Z
    Acta Med Croatica; 2006; 60(2):109-12. PubMed ID: 16848199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE
    Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy.
    Gartaganis SP; Mela EK; Katsimpris JM; Petropoulos JK; Karamanos NK; Koliopoulos JX
    Ophthalmic Surg Lasers; 1999; 30(8):647-52. PubMed ID: 10507567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
    Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E; Stefánsson E; Bjarnadóttir G; Sigurjónsdóttir JF; Gudmundsdóttir G; Masson M; Loftsson T
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the European Glaucoma Prevention Study.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I; Clineschmidt C; Polis A; Taylor J; Shedden A; Laibovitz R
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.
    Onal S; Gozum N; Gucukoglu A
    Ophthalmic Surg Lasers Imaging; 2005; 36(6):457-62. PubMed ID: 16355950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorzolamide X apraclonidine in the prevention of the intraocular pressure spike after Nd : YAG laser posterior capsulotomy.
    Arieta C; Amaral M; Matuda E; Crosta C; de Carvalho Moreira Filho D; José N
    Curr Eye Res; 2002 Oct; 25(4):237-41. PubMed ID: 12658557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effect of dorzolamide hydrochloride to patients taking travoprost: a retrospective study.
    Boyer S; Gay D
    Optometry; 2008 Sep; 79(9):501-4. PubMed ID: 18722961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery.
    Zohdy GA; Rogers ZA; Lukaris A; Sells M; Roberts-Harry TJ
    J R Coll Surg Edinb; 1998 Oct; 43(5):344-6. PubMed ID: 9803110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man.
    Gudmundsdottir BS; Petursdottir D; Asgrimsdottir GM; Gottfredsdottir MS; Hardarson SH; Jóhannesson G; Kurkov SV; Jansook P; Loftsson T; Stefánsson E
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):35-41. PubMed ID: 24205991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.